Article By:
Michael J. Kramer
Sunday, December 8, 2019 4:38 PM EST
Stocks will try to pick up where they left off on Monday, following the strong jobs report. This week will feature CPI, PPI, the Fed, and the ECB. With that, the S&P 500 will try to advance to 3,200 its next level of significant resistance.
Regeneron Pharmaceuticals’ Dupixent Has Multi-Billion-Dollar Potential: Polen Capital
Note it has only been approved in Japan. And only for those whom existing treatments are ineffective. So that's a MUCH smaller market. How small I don't know. But not enough to make me bite. $REGN